Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists
Authors:
- Emmanuelle PetitfrèreEPEmmanuelle Petitfrère
- Gérard PotronGPGérard Potron
- 1 April 1995
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 78 (1) , 33-42
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil‐derived agonistsBritish Journal of Haematology, 1992
- Platelet Activating Factor (PAF)Drugs, 1991
- New trends in PAF antagonist research: A new series of potent hetrapazine-derived PAF antagonistsInflammation Research, 1991
- Superoxide Dismutase (SOD) and the Paf-Antagonist (BN 52021) Reduce Small Intestinal Damage Induced by Ischemia-ReperfusionFree Radical Research Communications, 1991
- Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cellsBiochemical Pharmacology, 1990
- Preformed PAF‐acether and lyso PAF‐acether are bound to blood lipoproteinsFEBS Letters, 1988
- The rapid polyphosphoinositide metabolism may be a triggering event for thrombin-mediated stimulation of human plateletsBiochemical and Biophysical Research Communications, 1983
- Relationship between Fibrinogen Binding and the Platelet Glycoprotein Deficiencies in Glanzmann's Thrombasthenia Type I and Type IIBritish Journal of Haematology, 1981
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodJournal of Pharmacological Methods, 1980
- Adenosine 3′,5′ cyclic monophosphate assay at 10−15 mole levelAnalytical Biochemistry, 1973